Cargando…
Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031052/ https://www.ncbi.nlm.nih.gov/pubmed/29762740 http://dx.doi.org/10.1093/ndt/gfy135 |
| _version_ | 1783337243562213376 |
|---|---|
| author | Dekkers, Claire C J Wheeler, David C Sjöström, C David Stefansson, Bergur V Cain, Valerie Heerspink, Hiddo J L |
| author_facet | Dekkers, Claire C J Wheeler, David C Sjöström, C David Stefansson, Bergur V Cain, Valerie Heerspink, Hiddo J L |
| author_sort | Dekkers, Claire C J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6031052 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60310522018-07-10 Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease Dekkers, Claire C J Wheeler, David C Sjöström, C David Stefansson, Bergur V Cain, Valerie Heerspink, Hiddo J L Nephrol Dial Transplant Erratum Oxford University Press 2018-07 2018-05-11 /pmc/articles/PMC6031052/ /pubmed/29762740 http://dx.doi.org/10.1093/ndt/gfy135 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Erratum Dekkers, Claire C J Wheeler, David C Sjöström, C David Stefansson, Bergur V Cain, Valerie Heerspink, Hiddo J L Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title | Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title_full | Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title_fullStr | Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title_full_unstemmed | Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title_short | Effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b–4 chronic kidney disease |
| title_sort | effects of the sodium–glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and stages 3b–4 chronic kidney disease |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031052/ https://www.ncbi.nlm.nih.gov/pubmed/29762740 http://dx.doi.org/10.1093/ndt/gfy135 |
| work_keys_str_mv | AT dekkersclairecj effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease AT wheelerdavidc effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease AT sjostromcdavid effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease AT stefanssonbergurv effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease AT cainvalerie effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease AT heerspinkhiddojl effectsofthesodiumglucosecotransporter2inhibitordapagliflozininpatientswithtype2diabetesandstages3b4chronickidneydisease |